Beryl Drugs Limited (BOM:524606)

India flag India · Delayed Price · Currency is INR
23.00
+0.99 (4.50%)
At close: Apr 28, 2026
3.60%
Market Cap 111.32M
Revenue (ttm) 176.65M
Net Income (ttm) 141.00K
Shares Out 5.07M
EPS (ttm) 0.03
PE Ratio 789.53
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,895
Average Volume 5,505
Open 20.91
Previous Close 22.01
Day's Range 20.91 - 23.11
52-Week Range 15.92 - 30.00
Beta 0.01
RSI 47.91
Earnings Date May 29, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524606
Full Company Profile

Financial Performance

In fiscal year 2025, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.69%.

Financial Statements

News

There is no news available yet.